phospho ddr2y740 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
93
Structured Review
R&D Systems
phospho ddr2y740
Phospho Ddr2y740, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+ddr2y740/Human+Phospho-DDR1%2FDDR2+(DDR1+Y796%2C+DDR2+Y740)+Antibody/pm40527088-107-3-4
Average 93 stars, based on 30 article reviews
Phospho Ddr2y740, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+ddr2y740/Human+Phospho-DDR1%2FDDR2+(DDR1+Y796%2C+DDR2+Y740)+Antibody/pm40527088-107-3-4
Average 93 stars, based on 30 article reviews
phospho ddr2y740 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Expressing:Article Title: Biomimetic nanoplatforms for combined DDR2 inhibition and photothermal therapy in dense breast cancer treatment. Article Snippet: Breast cancer treatment remains challenging due to the dense, fibrotic tumor microenvironment (TME), which is dominated by cancer-associated fibroblasts (CAFs), hinders drug delivery and promotes therapy resistance.. While photothermal therapy (PTT) can induce localized tumor ablation, its efficacy is often limited by poor nanoparticle penetration and CAF-mediated immune suppression.. Here, we developed M@P-WIs, a biomimetic nanoplatform that combines PTT with targeted CAF modulation. Western Blot:Article Title: Biomimetic nanoplatforms for combined DDR2 inhibition and photothermal therapy in dense breast cancer treatment. Article Snippet: Breast cancer treatment remains challenging due to the dense, fibrotic tumor microenvironment (TME), which is dominated by cancer-associated fibroblasts (CAFs), hinders drug delivery and promotes therapy resistance.. While photothermal therapy (PTT) can induce localized tumor ablation, its efficacy is often limited by poor nanoparticle penetration and CAF-mediated immune suppression.. Here, we developed M@P-WIs, a biomimetic nanoplatform that combines PTT with targeted CAF modulation. Immunofluorescence:Article Title: Biomimetic nanoplatforms for combined DDR2 inhibition and photothermal therapy in dense breast cancer treatment. Article Snippet: Breast cancer treatment remains challenging due to the dense, fibrotic tumor microenvironment (TME), which is dominated by cancer-associated fibroblasts (CAFs), hinders drug delivery and promotes therapy resistance.. While photothermal therapy (PTT) can induce localized tumor ablation, its efficacy is often limited by poor nanoparticle penetration and CAF-mediated immune suppression.. Here, we developed M@P-WIs, a biomimetic nanoplatform that combines PTT with targeted CAF modulation. |